Insider trades
Simrat Randhawa, EVP of Dianthus Therapeutics DNTH, has filed 2 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $12.5M. The latest trade was on 06/01.
Simrat Randhawa
EVP, Head of R&D
- Company
- Dianthus Therapeutics DNTH
- First filing
- 23/09/25
- Trades
- 41 trades
- Buys / sales
- 2 / 8
- 12-month net buying
- −$12.5M
- Last trade
- 06/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
DNTH | Open-market sale10b5-1 plan | 06/01 | 06/02 | 26,530 sh3 trades | $90.62avg. | $2,404,076.95 | −86.9% |
| Open-market sale10b5-1 plan | 03/12 | 03/13 | 33,830 sh | $81.48 | $2,756,468.4 | −100.0% | |
DNTH | Open-market sale10b5-1 plan | 25/11/13–25/11/14 | 25/11/14 | 196,538 sh4 trades | $37.55avg. | $7,379,887.46 | −98.0% |
DNTH | Open-market buy | 23/09/21–23/09/22 | 23/09/25 | 4,000 sh2 trades | $13.20avg. | $52,800 | No record |